Difference between revisions of "Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5 (Q9818)"
Jump to navigation
Jump to search
(Created claim: PubMed ID (P140): 18203652, #quickstatements; #temporary_batch_1590001671040) |
(Created claim: Publication Date (P100): 2008, #quickstatements; #temporary_batch_1590002823654) |
||||||||||||||
Property / Publication Date | |||||||||||||||
+ | 2008
| ||||||||||||||
Property / Publication Date: 2008 / rank | |||||||||||||||
+ | Normal rank |
Revision as of 19:47, 20 May 2020
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
Language | Label | Description | Also known as |
---|---|---|---|
English |
Riechelmann H, et al. Oral. Oncol. (2008) cited as Ref 555 in DOI: 10.1038/s41392-020-0110-5
|
Cited in: "Targeting cancer stem cell pathways for cancer therapy" in Signal Transduct Target Ther; 2020 ; 5 8
|
Statements
Riechelmann H
0 references
2008
0 references